Weight loss leads to notable muscle loss, study finds

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with high rates of muscle loss relative to the amount of weight lost.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup